CN

ExCell Bio.

ExCell Biotech Co., Ltd. founded in 2013,which originated from the well-known brand--genetimes,is one of the largest suppliers of biological reagents and consumables in China.Many of the company's products fill the domestic gap.Our company is the leading enterprise of the core raw materials in the upstream of China's biomedical industry, and also the first member unit of the International Association of Serum Industry (ISIA), the national high-tech enterprise, the engineering technology research center of cell therapy culture medium and gene detection reagent in Suzhou, the enterprise of reaching the standard of the quality of serum production in China, and the most potential investment in Suzhou in 2017.Our company specializes in providing world-class raw materials and technical services for customers in the fields of biopharmaceuticals, precision medicine and so on.

At present, the company has two major product lines: industrial and therapeutic culture products represented by fetal bovine serum, stem cell culture reagents, cell therapy and serum-free culture media for biopharmaceuticals; cell function identification products represented by NGS library building, protein residue detection, ELISA detection kits for Alzheimer's disease, etc. And so on. The company's vision is to become a world-class evergreen enterprise with independent intellectual property rights in the field of life science. Its mission is to accelerate the application of life science and technology and continuously improve human health.



The company has management and marketing centers in Shanghai, Beijing, Guangzhou, Shenzhen, Hong Kong and other major cities in the country, as well as branches in the United States, Australia and Uruguay. At present, the company has served more than 10,000 customers in universities, research institutes, hospitals, biopharmaceuticals, gene sequencing and other corporate customers.



The company will always bear in mind the original intention of becoming a world-class Chinese company with independent intellectual property rights in the field of life sciences, take the development of domestic biological reagent industry as its own responsibility, keep forging ahead, continue to innovate, and never stop on the road of entrepreneurship and innovation.